Filing excerpt
In June 2026 we entered into a definitive agreement to acquire all of the issued and outstanding shares of RayThera Inc., a pri
Source: Autobound Signal API · 74 signals tracked for Biogen · updated
Get Biogen's live signals in Claude or ChatGPT, or by API
What changed at Biogen this week? Use Autobound signals for biogen.com.Biogen entered into a definitive agreement in June 2026 to acquire all issued and outstanding shares of RayThera Inc. This acquisition may require regulatory, IT, and clinical integration support upon deal closing.
Filing excerpt
In June 2026 we entered into a definitive agreement to acquire all of the issued and outstanding shares of RayThera Inc., a pri
What this signalsIntegration work after a deal often opens needs for new systems and services.
sec-10qacquisitionAnnouncedGet every 10-Q signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/2b1ab40e-3354-469e-994b-f0fa3835a9ef returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "2b1ab40e-3354-469e-994b-f0fa3835a9ef",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-11-09T06:30:46.378+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen entered into a definitive agreement in June 2026 to acquire all issued and outstanding shares of RayThera Inc. This acquisition may require regulatory, IT, and clinical integration support upon deal closing.",
"metrics": {
"timeframe": "current_quarter"
},
"quarter": "Q2",
"summary": "Entered definitive agreement to acquire RayThera Inc. in June 2026",
"excerpts": "In June 2026 we entered into a definitive agreement to acquire all of the issued and outstanding shares of RayThera Inc., a pri",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000075/biib-20260630.htm",
"filing_date": "2026-07-29",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "06/30",
"period_end_date": "2026-06-30",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/2b1ab40e-3354-469e-994b-f0fa3835a9ef \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.